Stock Analiz

Larimar Therapeutics, Inc. (LRMR) stock forecast and price target

Price $3.02 · data as of November 13, 2026

12-month price target

Average target$14.40
Upside / downside+376.8%
Analysts10
ConsensusStrong buy
Low $5.00Average $14.40High $26.00

Gold marker: average target · white marker: today’s price ($3.02)

Analyst ratings

Strong buy 2Buy 9Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-1.37+39.6%$0
Next fiscal year
ends December 31, 2027
$-1.06+22.7%$42M
Quarter after
ends December 31, 2026
$-0.39+46.0%$0

Consensus of the analysts covering Larimar Therapeutics, updated daily. In the last 30 days 6 estimates were raised and 0 lowered.

Frequently asked questions

What is the Larimar Therapeutics stock price target?

The average 12-month target from 10 analysts is $14.40, 376.8% above the current price of $3.02 Targets range from $5.00 to $26.00.

Is Larimar Therapeutics a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 9 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Larimar Therapeutics expected to earn?

Analysts expect EPS of $-1.37 for the fiscal year ending December 31, 2026 and $-1.06 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.